Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine–Gass syndrome: a prospective case series

[1]  A. Joussen,et al.  Chapter 28 – Mechanisms of Macular Edema and Therapeutic Approaches , 2016 .

[2]  BucoloClaudio,et al.  Intravitreal triamcinolone acetonide in the treatment of ophthalmic inflammatory diseases with macular edema: a meta-analysis study. , 2015, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[3]  Waseem Al Zamil.  Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema , 2014, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[4]  S. Whitcup,et al.  Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. , 2014, Ophthalmology.

[5]  M. Errera.  Dexamethason implant versus posterior sub‐tenon triamcinolone acetonide for treatment of macular edema and/or vitritis in intraocular inflammatory diseases. Retrospective cases‐series , 2014 .

[6]  C. Ostri.  Intraocular surgery in a large diabetes patient population: risk factors and surgical results , 2014, Acta ophthalmologica.

[7]  M. Kosker,et al.  Phacoemulsification with intraocular lens implantation in patients with anterior uveitis , 2013, Journal of cataract and refractive surgery.

[8]  H. Khairy,et al.  Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery , 2013, Clinical ophthalmology.

[9]  T. Sørensen,et al.  Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants , 2013, Clinical ophthalmology.

[10]  J. Garcia-Arumi,et al.  Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome. , 2013, Investigative ophthalmology & visual science.

[11]  Lihteh Wu,et al.  Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group , 2012, International Ophthalmology.

[12]  T. Yilmaz,et al.  Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review , 2012, Eye.

[13]  C. Lobo.  Pseudophakic Cystoid Macular Edema , 2011, Ophthalmologica.

[14]  C. Schönfeld,et al.  Cystoid Macular Edema after Complicated Cataract Surgery Resolved by an Intravitreal Dexamethasone 0.7-mg Implant , 2011, Case Reports in Ophthalmology.

[15]  M. Zierhut,et al.  Successful Treatment of Chronic Pseudophakic Macular Edema (Irvine-Gass Syndrome) with Interferon Alpha: A Report of Three Cases , 2011, Ocular immunology and inflammation.

[16]  L. Jampol,et al.  PHARMACOLOGIC THERAPY OF PSEUDOPHAKIC CYSTOID MACULAR EDEMA: 2010 Update , 2011, Retina.

[17]  S. Lightman,et al.  New Developments in Corticosteroid Therapy for Uveitis , 2010, Ophthalmologica.

[18]  Y. Ogura,et al.  Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes , 2009, Japanese Journal of Ophthalmology.

[19]  George A. Williams,et al.  Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. , 2009, American journal of ophthalmology.

[20]  P. Szurman,et al.  Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema , 2008, Journal of cataract and refractive surgery.

[21]  George A. Williams,et al.  Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. , 2007, Archives of ophthalmology.

[22]  J. Jonas,et al.  Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. , 2003, American journal of ophthalmology.

[23]  Y. Guex-Crosier,et al.  Posterior sub-Tenon’s steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  W. Freeman,et al.  The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. , 1998, American journal of ophthalmology.

[25]  J. Sipperley,et al.  A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. , 1997, Ophthalmology.

[26]  H. Flynn,et al.  Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. , 1995, American journal of ophthalmology.

[27]  J. Sparrow,et al.  Vitreous loss in planned extracapsular cataract extraction does lead to a poorer visual outcome , 1995, Eye.

[28]  L. Laatikainen,et al.  Cystoid macular oedema after complicated cataract surgery and implantation of an anterior chamber lens , 1994, Acta ophthalmologica.

[29]  R. Steinert,et al.  Neodymium:YAG laser anterior vitreolysis for Irvine‐Gass cystoid macular edema , 1989, Journal of cataract and refractive surgery.

[30]  T. Cakiner-Egilmez,et al.  Diabetes and cataract surgery: preoperative risk factors and positive nursing interventions. , 2014, Insight.

[31]  A. Flach.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. , 1998, Transactions of the American Ophthalmological Society.

[32]  P. Bhattacherjee.  The role of arachidonate metabolites in ocular inflammation. , 1989, Progress in clinical and biological research.